hVIVO – Institutional Holdings Building Up After This Week’s Strong First Half Report 

Earlier this week hVIVO (LON:HVO) reported its Interim Results to end-June, they showed a 30.6% first-half growth in revenues to £35.6m, while its EBITDA was 67.6% higher at £8.7m, with end-period cash up at £37.1m (£1.3m). 

The group is a fast-growing specialist contract research organisation and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials.  

Management Comment 

CEO Yamin ‘Mo’ Khan stated that: 

“After an exceptionally strong first half with record revenues and margins, hVIVO enters the remainder of the year with FY24 revenue guidance fully contracted and good visibility into 2025.  

We continue to expand our pipeline, not only in human challenge trials but also in our new revenue streams including clinical site studies, standalone laboratory services, and volunteer / patient recruitment.  

Operational efficiencies are set to continue to improve with the expansion of our services, improved automation, and the move to our new facility in Canary Wharf. 

We are pleased to reaffirm our full-year revenue guidance of £62 million and expect EBITDA margins to be at the upper end of market expectations.  

We are targeting Group revenue of £100 million by 2028 – this growth will be underpinned by the increased capacity of our facilities, our strong cash position, and our long-term sustainable growth model.” 

Institutional Buying 

As I have detailed previously, the City investing institutions are becoming ever more aware of this group’s potential and have been gradually building up positions in the group’s equity. 

Investors like Canaccord Genuity Wealth Management (3.19%), Rathbones Investment Management (5.01%), and JP Morgan Asset Management (UK) (7.03%) each have taken stakes in the growing business. 

However, the one professional investor really showing its faith in hVIVO’s prospects is Octopus Investments, which in the middle of July held just 3.1% of the HVO equity. 

Within that month, it had more than doubled its holding to 7.61%. 

At the start of August, it was up to 8.0%. 

This morning it has been announced that on Tuesday of this week (10th) it upped its stake to 9.08%, some 61,801,224 shares. 

The group’s shares are currently trading at around the 29p level, whilst City analysts have Price Objectives ranging from 36p to 42p for its shares. 

Technology Minerals to slash costs in absence of meaningful revenue

Technology Minerals has unveiled a comprehensive cost reduction programme aimed at streamlining operations and bolstering efficiency across the organisation today.

After generating zero revenue in the six month period to 31st December, the firm is taking steps to cut costs to ‘drive productivity’. One would assume the company is yet to generate enough revenue to support its wage bill. We will find out more in the full-year report.

Steps outlined by Technology Minerals include a significant redundancy scheme to reduce the total workforce, substantial cuts to head office costs, and an ongoing, thorough assessment of all service providers.

Philip Beard has agreed to step down from his roles as Independent Non-Executive Director and Chairman of the Remuneration Committee with immediate effect.

The reduction in Independent Non-Executive Directors has prompted a review of the Board’s future composition, which is likely to be a lot leaner in the future.

“These cost reduction measures have been identified as part of the Board’s efforts to increase efficiencies and drive productivity throughout every level of the business,” said Robin Brundle, Chairman of Technology Minerals.

“On behalf of the Board, I’d like to extend our thanks and appreciation to Phil for his contribution to the Company. We are grateful for all the strategic guidance Phil has provided to Technology Minerals and wish him the best in his future endeavours.”

Those investors seeking a profitable circular economy metals recycling company should look at UK-listed Majestic Corporation.

The company generated $29m revenue in the year ended 31st December, and profit before tax grew 149%. Majestic recycles a range of e-waste and renewable energy waste and is expanding in the UK after acquiring a business based in North Wales.

AB Foods shares are oversold, is now the time to buy?

Primark-owner AB Foods took a pasting after the group said Primark sales would fall in the second half of the year due to poor weather and low footfall.

After losing roughly 18% of their value since August highs, AB Foods shares are currently firmly in oversold territory with an RSI of 21. The sharp decline should pique the interest of investors seeking an entry point with the long-term investment case intact.

The Weather

AB Foods has blamed slow sales in the second half on the weather. We all know how disappointing the British summer was this year, and companies heavily reliant on good weather to drive consumer purchases have been hit hard. AB Foods isn’t the only company to attribute bad sales to poor weather.

Primark is particularly reliant on in-store sales. Although it has been strengthening its online presence, Primark is still driving people into its stores by focusing on click-and-collect and the online shopping experience provides little help during a washout summer.

However, AB Foods used the same excuse earlier this year for slow sales growth in the first half. The winter was too warm and the summer too cold, according to AB Foods.

Investors have evidently grown tired of the same excuse and dumped the stock. For those with longer time horizons, this may provide an opportunity.

Primark’s same-store sales growth is fairly steady, and the company relies on new store openings for growth—this has proved a fruitful pursuit. The company is expanding across southern Europe, and new store openings are expected to increase US sales by 25% in the second quarter.

‘Build it, and they will come’ seems to be working for Primark. The brand’s low-cost clothing is a hit wherever it opens a new store.

The company plans further expansion in the US, which promises further growth in the years to come. Primark are also eyeing the Gulf Cooperation Council markets after signing an agreement with a local partner.

Investors should note that despite uneven sales growth, Primark’s margins are strong, and they expect operating margins to be higher in H2 2024 than H2 2023.

Food

AB Foods (as the name suggests) isn’t just the owner of Primark, and food sales account for roughly half group sales.

Sales from the food side of the business are expected to be steady in the second half and pose no major concern for investors, despite agriculture and sugar’s risk of adverse weather conditions. AB Foods uses the word ‘weather’ 15 times in its interim report to give you an idea of how much its business is dependent on Mother Nature.

All three food-related divisions saw operating profits grow in the first half of the year. However, due to sugar pricing in Europe, the company expects a disappointing second half for the unit, which may have contributed to the recent selloff.

Valuation

From a valuation perspective, AB Foods offer good value at 2,170p. They trade at 11x forward earnings and 15x historical earnings. The historical earnings multiple is reasonable, and the forward multiple, should estimates be meet, suggests very good value.

Don’t expect fireworks from AB Foods, but Primark’s overseas expansion plans and stable long-term earnings from the food business should support a move back to all-time highs above 3,000p.

AIM movers: Marlowe demerger and Fevertree Drinks hampered by weather

3

Video editing technology developer Blackbird (LON: BIRD) continues to rebound following the interims earlier in the week. The share price improved 22.7% to 6.75p. Revenues fell 30% to £692,000 because of the ending of the A+E deal and lower operating costs meant that the loss was reduced. Cash burn was similar at £1.9m, leaving net cash of £5.6m. The elevate.io product was released in March and monetisation starts in early 2025.

Online gaming company Gaming Realms (LON: GMR) continues to make good progress and generate cash. The share price is also higher after interims and it is 39p, up 8.33%. Interim revenues improved 18% to £13.6m, even though there was not a repeat of the brand licensing deals in the year before, and pre-tax profit increased from £2.4m to £3.5m. The growth is international, although North America is the fastest growing with West Virginia going live after the period end. Even after capitalised development costs, net cash improved to £9.6m.

Marlowe (LON: MRL) is demerging the occupational health division as an independent AIM company called Optima Health by the end of September. Shareholders will receive one share for each Marlowe share held. Marlowe will focus on testing, inspection and certification operations. So far, £41m of the £75m share buy back has been spent. Marlowe continuing revenues are forecast to be £306m and pre-tax profit £13m. The share price increased 6.98% to 460p.

Wind turbine optimisation technology developer Windar Photonics (LON: WPHO) increased interim revenues by 71% to €2.3m and there was a small EBITDA loss. The second half order book is worth €3.8m. A move from loss to a full year profit of €2.7m is forecast. The share price is 6.17% ahead at 43p.

FALLERS

Wet weather hit sales at Fevertree Drinks (LON: FEVR) in the UK and Europe. That was offset by growth in other regions, but group revenues fell from £175.6m to £172.9m. Even so, underlying pre-tax profit rebounded from £4.7m to £13.2m. Cash is £65.9m. Second half revenues are expected to grow by between 7% and 10% following more positive trading in July and August. The share price declined 11.3% to 765.25p.

Optimisation software provider Checkit (LON: CKT) continues to reduce its loss on the back of a 16% increase in interim revenues to £6.7m. Annualised recurring revenues are £13.8m and that underpins the full year revenues forecast of £14.2m. Net cash was £7m at the end of July 2024 and higher R&D spending means that year-end cash is likely to be slightly lower than previously expected at around £5m. The share price fell 10.9% to 20.5p.

Energy optimisation services provider Inspired (LON: INSE) interim revenues edged up from £44.6m to £45m and pre-tax profit dipped from £6.2m to £5.7m. That was lower than forecast. Optimisation revenues declined, but product mix meant that margins were better. Cross-selling is helping to grow the ESG division and other parts of the business. Net debt is £57.6m. There is only £2.2m of contingent consideration due to be paid. Debt should start to decline over the next few years. The share price dipped 5.34% to 62p.

Ex-dividends

Churchill China (LON: CHH) is paying an interim dividend of 11.5p/share and the share price is unchanged at 925p.

Colefax Group (LON: CFX) is paying a final dividend of 2.9p/share and the share price is unchanged at 860p.

DSW Capital (LON: DSW) is paying a final dividend of 0.75p/share and the share price is unchanged at 60p.

Globalworth Real Estate Investments (LON: GWI) is paying an interim dividend of 10 cents/share and the share price is unchanged at 266 cents.

Midwich (LON: MIDW) is paying an interim dividend of 5.5p/share and the share price is 0.5p higher at 320.5p.

Uniphar (LON: UPR) is paying an interim dividend of 0.67 cents/share and the share price is unchanged at 225p.

Trainline shares top FTSE 250 as ticket sales surge

Trainline shares were at the top of the FTSE 250 leaderboard on Thursday after the ticketing app announced strong sales growth in the first half of the year.

“Trainline sales are tracking ahead of analyst estimates with more consumers switching to digital tickets being one of the main drivers. It may not feel like it for many commuters but there has also been a reduced effect of strike action in comparison to last year,” said Adam Vettese, Market Analyst at investment platform eToro.

Trainline enjoyed revenue growth of 16% year-on-year in the first half, driven by a 13% jump in ticket sales. Investors will be pleased to see strength in the UK after a couple of soft periods for Trainline.

“Double-digit gains in net ticket sales and group revenue point to a fantastic first-half period for Trainline,” said AJ Bell investment director, Russ Mould.

“Acting as a big tailwind is a structural shift in the UK for people to use digital tickets rather than paper ones. As more people become accustomed to scanning their phone to get through station barriers, the bigger the opportunity for Trainline to position itself as the go-to place for buying these types of tickets.

“A second tailwind is increased carrier competition in mainland Europe, primarily in Spain and Italy. Trainline has been able to position itself as an easy way to navigate the increasingly complex travel system and get good deals.”

FTSE 100 surges higher after strong US session

The FTSE 100 had a strong start to Thursday as London followed a decent for US shares ahead of the ECB’s rate decision later.

The catalyst was a surge in US tech stocks overnight, helping drive a turnaround in the S&P 500 yesterday. Markets also appeared to cheer the US CPI reading which almost nails on a rate cut next week. Such was the scale of the buying, the S&P 500 rallied around 140 points from yesterday’s lows into the close. The move from low to high was about 2.8% of the index value. 

“US markets bounced after the CPI inflation print all but secured the Fed’s first rate cut next week,” said Matt Britzman, senior equity analyst, Hargreaves Lansdown.

“CPI isn’t the Fed’s preferred inflation measure, but with a little bit of jigging, we can get a decent idea of what the preferred PCE number might look like, and it’s all starting to paint the same picture – inflation that’s behaving well. Markets are pricing in an 87% chance of a 0.25% cut, and there wasn’t much in this data to suggest a bolder move is needed.

An upbeat Nvidia CEO helped fire up AI-related stocks that were responsible for much of yesterday’s gains. The AI trade has been under pressure in recent weeks, but the 8% surge in Nvidia overnight shows there is still plenty of interest in the chipmakers, and investors are happy to continue deploying cash in the sector.

“Tech was back leading the charge, with the S&P 500’s chip sector up 6.65%. Nvidia’s had a bumpy ride of late, but markets were encouraged by CEO Jensen Huang’s bullish conference commentary on demand,” Britzman said.

The risk on trade was evident in the FTSE 100’s cyclical sectors, with miners surging higher and financials having a good day.

Copper miner Antofagasta was the top gainer, adding over 3.5%. Anglo American was not far behind, rising 3.2%. The lack of technology shares in London means investors often pick the next best thing in the cyclical mining sector when they are feeling confident about the outlook.

M&G was the top faller, but only because the stock traded ex-dividend today.

Investors will tune into the ECB’s rate decision later today, when we are expected to see another rate cut. A rate cut from the ECB will more than likely be followed by similar moves by the Fed and Bank of England next week.

Fevertree shares sink as growth stalls

It seems a long time ago that Fevertree shares were the talk of the town as the group established itself as a leading tonic brand in the UK and entered the US market. 

Fevertree shares are now worth less than 25% of what they were at their highs, and growth is disappointingly slow.

Once considered a drinks market disruptor, the group didn’t produce any revenue growth in the first half. Poor weather contributed to the soggy sales, but using that excuse usually means a company has nearly peaked in market share terms.

”Fevertree shareholders might be nursing sore heads this morning as the premium mixers maker posted a disappointing trading update, cutting its annual revenue growth forecast,” said Mark Crouch, Market Analyst at investment platform eToro.

Although the group enjoyed sales growth in the US in the first half, it was entirely offset by slowing sales in the UK. Total group revenue for the first half was down 2%.

The worrying signs for Fevertree were too much for investors on Thursday, and the stock slid by over 9%.

“Fevertree served up a mixed set of first-half results to investors. Revenue failed to bubble higher despite double-digit growth in the US where it continued to gain market share,” said Aarin Chiekrie, equity analyst, Hargreaves Lansdown.

“The US is already Fevertree’s largest contributor to the top line, but there’s plenty of room to run given the size of this vast market. Performance in the UK and Europe wasn’t so spritely. Despite gaining market share in these regions too, revenue fell 6% and 10% respectively as poor weather and a tough consumer backdrop weighed on demand in the second quarter. While the weather which convinced some punters to stay at home is out of Fevertree’s control, it’s doing well to manage the factors that are within its control. It’s kept a tight lid on costs in the first half, and profitability is improving quickly as shipping rates, energy costs on glass bottles and wider inflationary pressures ease.”

boohoo Group – The Grief Continues For Online Fashion Group – Valuations And Profit Hopes On Hold For The Moment 

The news that the boohoo Group (LON:BOO) is going to shut it 1.1m sq.ft distribution facility in Elizabethtown, Pennsylvania in the States must be part of the ongoing reconstruction going on within the group as a whole. 

The US distribution centre only started operating in August last year and will cease to operate within the next two months.  

The centre is operated by a third party and is on a property lease that the group will now sublet.  

That means that the changes to the online fashion business operations in the States will require quite a change to its distribution, which is expected to be brought back to the UK through its ‘state-of-the-art’ automated UK distribution centre in Sheffield. 

It is reported that the group remains excited about the opportunity in the US and has been developing wider routes-to-market strategies, the first of which is the recent launch of Nasty Gal in Nordstrom stores.  

The company is also said to be in advanced talks with major US brands with regard to new routes to market for other brands within the group. 

Recently the corporate news from the quoted business has not been positive. 

It has advisers currently thrashing through various refinancing options for its massive £325m debt. 

There is a sale and leaseback possibility for its 44,000 sq.ft. office in London’s West End. 

The Soho property was only acquired in 2021, with the group paying some £72m for the building. 

And now it is believed that the group has to take a £80m write-down for its US costs, while the US inventory will be returned to the UK centre in Sheffield. 

Analyst Views 

Analyst Katie Cousins at Shore Capital Markets stated that: 

“We have previously noted the Group’s struggle to gain traction in the US despite investing to grow market share and improve delivery times for consumers. 

To us, the short life of the US warehouse (previously stated as a key pillar of growth for Boohoo) is concerning, highlighting a naivety of the American market, along with a waste of time and resources.” 

Rachel Birkett at Zeus Capital noted the decisive action to cease supplying US customers from its distribution centre in Pennsylvania, as management continue to look at ways to drive a more sustainable, profitable business whilst also broadening routes to market. 

Until the group’s Interim Results are announced next month, Zeus is leaving its forecasts unchanged at revenues for the year to end-February 2025 of £1,478m (£1,461m) with halved adjusted pre-tax losses of £15.3m (loss of £34.3m). 

For next year Birkett has estimates of £1,553m sales, and just £1.8m of losses. 

Over at Peel Hunt its analyst John Stevenson has placed the group ‘under review’ as it worries about the recovery at the online fast fashion retailer. 

Sensibly he has placed his ‘buy’ recommendation and target price of 75p ‘under review’ as he noted that US volumes had been ‘well below full-year 2022 levels’, pushing the group back to a ‘UK-led distribution model, which is significantly more profitable’. 

He commented that the company is still committed to the US, with its Pretty Little Things Autumn pop-up college tour back on. 

Stevenson suggests that while a US recovery is still on the agenda, utilising the most efficient distribution channel should improve US margins materially. 

In My View 

I wonder what Mike Ashley’s views are about the company, his Frasers Group (LON:FRAS) is its largest shareholder with 26.18% of the £355m valued equity and he has recently added to his stake. 

However, in the market there are currently Open Short Positions on some 5.44% of the group’s stock. 

With its shares, which were up to 43p last Christmas but are currently trading at 28p, I too would be a seller and not a buyer – certainly not until more news is released on just how the group is faring with sorting out its debts and getting back into profits again – could that be sometime next month? 

I am not holding my breath!

FTSE 100 slips as UK economy flatlines, Rentokil sinks

The FTSE 100 was marginally lower on Wednesday, reflecting minor disappointment with soft UK GDP figures that hit some of London’s more UK-centric large caps.

After flatlining in June, UK GDP growth again produced zero growth in July, raising concerns about the health of the UK economy in a period that should have seen some uplift from various sporting events.

Some may blame the weather, but two consecutive months of zero growth are concerning, and investors sold off UK-focused sectors such as housebuilders and retailers on Wednesday.

Persimmon and Berkeley Group Holdings were down more than 1% as the market digested the construction component of GDP and a slowdown in July.

“A rise in output from the large services sector was offset by a fall in production and construction during the month. This picture of stagnation is another piece in the jigsaw for Bank of England policymakers to consider when they meet next week,” said Susannah Streeter, head of money and markets, Hargreaves Lansdown.

“There may be slightly heightened concerns around the table that the economy is on the cusp of a downturn. This will reinforce expectations for two rate cuts in the months to come, but the jury is still very much out when it comes to next week’s decision. Financial markets have been assessing the chance that rates will be kept on hold as above 75%, so this data point alone is unlikely to move the dial significantly.”

Rentokil Initial

Rentokil Initial shares plunged on Wednesday after the pest control group made worrying sounds about its North American business. The company said branch integration and softer sales is likely to lead to a £20m drop in operating profit. The news wasn’t taken well by investors and shares were down 17% at the time of writing.

“You would think pest control is a stable business with consistent demand but that consistency hasn’t been reflected in the performance of Rentokil of late,” said Russ Mould, investment director at AJ Bell.

“Its latest warning is a bit of mess. While its business in the rest of the world is getting on OK, the company is struggling in North America.

“Weaker than expected revenue has been compounded by problems of the company’s own making such as insufficient control of costs hitting profitability.”

Entain was the top gainer on Wednesday as the gambling company continued its rally after recent upbeat news from US operations. Entain was 2% higher shortly before lunch.

AIM movers: Chariot disappoints and Greatland Gold buys back Havieron

0

Broadcast technology developer Pebble Beach Systems (LON: PEB) will be demonstrating how well its PRIMA platform works with NVIDIA Holoscan for Media at a major industry exhibition in Amsterdam. The backing of NVIDIA for the technology is a positive. The share price improved 19.6% to 13.15p.

Shore Capital has upgraded animal feed additives supplier Anpario (LON: ANP) after it reported 11% higher interim revenues of £17m on the back of a much greater rise in volumes and slightly lower pricing. Raw material costs have stabilised. Full year revenues expectations have been raised from £33m to £34m, while the pre-tax profit estimate is increased from £3.9m to £4.4m, up from £3.5m in 2023. The share price is 13.8% higher at 310p.

Arecor Therapeutics (LON: AREC) is presenting full data from the phase 1 clinical trial of AT278 in type 2 diabetes in Madrid. The data shows that the raid acting insulin treatment maintains its ultra-fast action whatever the type of diabetes or the body mass of the patient. Progress has been hampered by lack of funding and the presentation should raise interest from potential partners. The share price increased 3.23% to 80p.

FALLERS

Chariot (LON: CHAR) says work at a pilot hole to evaluate the Anchois Footwall prospect was abandoned due to it being water bearing. The presence of gas is indicated in the area. Drilling of the main hole has started. Further details are expected next week. Chariot has a 30% interest. The share price dived 44.5% to 3.54p, although it has recovered from its low on the day.

Greatland Gold (LON: GGP) shares returned from suspension after announcing the purchase of Newmont Corporation’s 70% stake in the Havieron gold-copper project, as well as 100% ownership of the Telfer gold-copper mine and other assets in the Paterson region. The total cost is $475m in cash and shares. A placing raised £248.6m ($325m) at 4.8p each, which is a 30% discount to the market price. Wyloo is subscribing up to $100m and Newmont Corporation will own more than 20% of the gold explorer.  Individual shareholders have the chance to participate in a retail offer via PrimaryBid to raise up to £6.8m. The share price slipped 21.6% to 5.45p.

Cannabis medicines developer Celadon Pharmaceuticals (LON: CEL) has raised £1.05m at 40p/share. The share price declined 22.9% to 40.5p. Celadon Pharmaceuticals is still talking to the previous equity subscriber that has not provided the funds, where the subscription price was 105p/share. There was £48,000 in the bank before the latest fundraising. There should be enough cash until the end of the year. A strategic collaboration with Valeos Pharma, which will licence some genetics for cultivation from Celadon Pharmaceuticals, which will use its expertise to help to increase yields and quality of cannabis. Celadon Pharmaceuticals will be able to use the crop grown by Valeos to supply its major European customer and generate a margin on the sale. The deal could also generate £1.7m of additional income based on increased yield and pricing.

Vast Resources (LON: VAST) has signed two agreements for the processing and marketing of products from the former Hanes gold mine in Romania. The first is with Explore Eco Mining, which will apply for permits for a processing facility and Vast Resources will receive 20% of the difference between revenues and production costs. The second agreement is with Albamin Industry for the marketing of 500 tonnes of polymetallic concentrate held in a dump. Vast Resources will receive 20% of the revenues and all expenses. The share price fell 12.5% to 0.105p.

AI-based digital advertising services provider Silver Bullet Data Services (LON: SBDS) slipped despite improving results. It has shed low margin work and still managed to grow revenues from £4.2m to £4.4m. Lower overheads meant that the reported loss fell from £1.8m to £1.6m. Management believes that the company can become EBITDA positive in October and this should be sustainable. Total bookings and committed revenues for 2024 have already reached £8.3m. Net debt was £2.6m at the end of June 2024. The share price is 5.23% lower at 72.5p.